NewEdge Advisors’s Astrana Health ASTH Stock Holding History

NewEdge Advisors’s Portfolio ASTH Stock Details ASTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-10	Closed	-$406	–	3964
2024 Q2	$406	Buy	+10	New	+$397	﹤0.01%	3589

Other funds holding ASTH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

325 Capital New York $274M AUM 49.96% 1-Year Est. Return

SteelPeak Wealth Woodland Hills, California $3.86B AUM 48.92% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

NewEdge Advisors's ASTH Position: Q3 2024 in Review

NewEdge Advisors sold out of Astrana Health (ASTH) in Q3 2024, closing a stake of 10 shares — an estimated $406 sold.

NewEdge Advisors first reported a position in ASTH in Q2 2024 and held it in 1 quarter. The position peaked at $406 in Q2 2024. 189 funds tracked by Wall St. Rank hold ASTH as of Q3 2024.

NewEdge Advisors reported no remaining Astrana Health position as of Q3 2024 after selling out during the quarter.
NewEdge Advisors sold 10 Astrana Health shares in Q3 2024, an estimated $406.
NewEdge Advisors first reported a position in Astrana Health in Q2 2024 and held it in 1 quarter.
NewEdge Advisors's Astrana Health position peaked at $406 in Q2 2024.
189 funds tracked by Wall St. Rank held Astrana Health as of Q3 2024.

Based on NewEdge Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.